
Bio-Techne
(NASDAQ) TECH
Bio-Techne Financials at a Glance
Market Cap
$8.05B
Revenue (TTM)
$1.22B
Net Income (TTM)
$81.10M
EPS (TTM)
$0.51
P/E Ratio
100.14
Dividend
$0.32
Beta (Volatility)
1.18 (Average)
Dividend
$0.32
Beta (Volatility)
1.18 (Average)
Price
$51.48
Volume
62,575
Open
$51.04
Price
$51.48
Volume
62,575
Open
$51.04
Previous Close
$51.48
Daily Range
$50.80 - $52.16
52-Week Range
$46.01 - $72.16
Dividend
$0.32
Beta (Volatility)
1.18 (Average)
Price
$51.48
Volume
62,575
Open
$51.04
Previous Close
$51.48
Daily Range
$50.80 - $52.16
52-Week Range
$46.01 - $72.16
TECH News

Techne Keeps Dividend Steady
Why Techne May Be About to Take Off
TECH: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bio-Techne
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
3,100
CEO
Kim Kelderman
Website
www.bio-techne.comHeadquarters
Minneapolis, MN 55413, US
TECH Financials
Key Financial Metrics (TTM)
Gross Margin
65%
Operating Margin
10%
Net Income Margin
7%
Return on Equity
4%
Return on Capital
5%
Return on Assets
3%
Earnings Yield
1.00%
Dividend Yield
0.01%
Payout Ratio
61.50%
Stock Overview
Market Cap
$8.05B
Shares Outstanding
156.45M
Volume
62.58K
Short Interest
0.00%
Avg. Volume
2.33M
Financials (TTM)
Gross Profit
$790.27M
Operating Income
$102.25M
EBITDA
$216.88M
Operating Cash Flow
$287.56M
Capital Expenditure
$31.01M
Free Cash Flow
$256.55M
Cash & ST Invst.
$162.19M
Total Debt
$444.06M
Bio-Techne Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$295.88M
-0.4%
Gross Profit
$191.28M
-1.3%
Gross Margin
64.65%
N/A
Market Cap
$8.05B
N/A
Market Cap/Employee
$2.60M
N/A
Employees
3,100
N/A
Net Income
$38.01M
+8.9%
EBITDA
$77.66M
+7.7%
Quarterly Fundamentals
Net Cash
$178.02M
+18.2%
Accounts Receivable
$184.61M
-15.3%
Inventory
$205.45M
+9.1%
Long Term Debt
$337.19M
-11.6%
Short Term Debt
$13.71M
+1.5%
Return on Assets
3.21%
N/A
Return on Invested Capital
4.91%
N/A
Free Cash Flow
$76.49M
-1.3%
Operating Cash Flow
$82.41M
-2.3%

